CEREBRAL-TUMORS AND ASSOCIATED DISORDERS STUDIED BY POSITRON EMISSION TOMOGRAPHY (PET) AND F-18-DEOXYGLUCOSE (FDG)

被引：0
|
作者：
PATRONAS, NJ [1 ]
BROOKS, RA [1 ]
SOKOLOFF, L [1 ]
DELAPAZ, RL [1 ]
SMITH, BH [1 ]
KORNBLITH, PL [1 ]
DICHIRO, G [1 ]
机构：
[1] NIH,CTR CLIN,DEPT RADIOL,BETHESDA,MD 20205
来源：
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY | 1983年 / 7卷 / 01期
关键词：
D O I：
10.1097/00004728-198302000-00079
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] CEREBRAL-TUMORS AND ASSOCIATED DISORDERS STUDIED BY POSITRON EMISSION TOMOGRAPHY (PET) AND F-18-DEOXYGLUCOSE (FDG)
    PATRONAS, NJ
    BROOKS, RA
    SOKOLOFF, L
    DELAPAZ, RL
    SMITH, BH
    KORNBLITH, PL
    DICHIRO, G
    RADIOLOGY, 1982, 144 (04) : 950 - 950
  • [2] POSITRON EMISSION TOMOGRAPHY (PET) WITH F-18-DEOXYGLUCOSE IN SMALL CELL-CARCINOMA
    KNOPP, MV
    STRAUSS, LG
    DIMITRAKOPOULOU, A
    MANKE, H
    BLATTER, J
    HELUS, F
    VANKAICK, G
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (10) : 1754 - 1754
  • [3] Positron emission tomography (PET) with 18F-deoxyglucose (FDG) in tumors of the skeleton system.
    Dimitrakopoulou-Strauss, A
    Heichel, T
    Lehner, B
    Strauss, LG
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 304P - 304P
  • [4] Positron emission tomography (PET) with C-11-ethanol and F-18-deoxyglucose (FDG) in hepatocellular carcinomas for therapy management.
    DimitrakopoulouStrauss, A
    Strauss, LG
    Gutzler, F
    Oberdorfer, F
    Irngartinger, G
    Doll, J
    Haberkorn, U
    vanKaick, G
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 261 - 261
  • [5] C-11-METHIONINE AND F-18-DEOXYGLUCOSE (FDG) IN THE POSTOPERATIVE MANAGEMENT OF PATIENTS WITH BRAIN-TUMORS WITH POSITRON EMISSION TOMOGRAPHY
    LAFRANCE, ND
    LINKS, J
    WILLIAMS, J
    HOLCOMB, H
    DANNALS, R
    RAVERT, H
    WILSON, A
    DREW, H
    HERDA, S
    WONG, D
    BREM, H
    LONG, D
    WAGNER, H
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 890 - 890
  • [6] 18fluorine-deoxyglucose (FDG) positron emission tomography (PET) in head/neck tumors.
    Chierichetti, F
    Polastri, L
    Cargnel, S
    Fini, A
    Vettorato, L
    Bagatella, F
    Ferlin, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1153 - 1153
  • [7] Quantitative analysis for myocardial glucose utilization using positron emission tomography and F-18-deoxyglucose
    Morita, K
    Katoh, C
    Koshinaga, K
    Adachi, I
    Shiga, T
    Mabuchi, M
    Itoh, Y
    Konno, M
    Kohya, T
    Kitabatake, A
    Kuge, Y
    Tsukamoto, E
    Tamaki, N
    POSITRON EMISSION TOMOGRAPHY IN THE MILLENNIUM, 2000, 1197 : 141 - 145
  • [8] Dynamic positron emission tomography (PET) with 18F-deoxyglucose (FDG) in done tumors:: Correlation of quantitative PET and gene expression.
    Strauss, LG
    Koomaegi, R
    Dimitrakopoulou-Strauss, A
    Heichel, T
    Lehner, B
    Bernd, L
    Ewerbeck, V
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 33P - 33P
  • [9] THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN THE STUDY OF CEREBRAL-TUMORS
    BROOKS, DJ
    BEANEY, RP
    THOMAS, DGT
    SEMINARS IN ONCOLOGY, 1986, 13 (01) : 83 - 93
  • [10] 18fluorine-deoxyglucose (FDG) positron emission tomography (PET) in the follow up of bowel tumors.
    Chierichetti, F
    Garraffa, G
    Cargnel, S
    Fini, A
    Vettorato, L
    Saitta, B
    Ferlin, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1147 - 1147
12345